Shire/Noven Daytrana Second-Line? Physicians Should Consider Oral Agents First, Cmte. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Psychopharmacologic Drugs Advisory Committee suggests that broad initial use of the methylphenidate patch should be discouraged because of skin sensitization issues.